Alamo Angels — Full Portfolio
3 tracked investments · listed companies and verified rows first
Arpeggio Bio develops pharmaceutical drugs that target transcription factors using artificial intelligence and RNA-sequencing technology, with lead programs in development for melanoma treatment and rare disease applications.
BiotechHealthtechBoulder, US
Joey Azofeifa(Founder)inLaura Norris(Executive Officer, Director)inTimothy Read(Executive Officer, Director)Eric Martin(Executive Officer)in
BoardAmit Mehta(Director)
Co-investorsATEM Capital FundFifty YearsFundersClubTau VenturesvenBio PartnersY Combinator+9 more
Darkhive builds integrated defense hardware and software solutions for military operations, including uncrewed systems, human-machine interfaces, and software platforms designed to enable rapid adaptation and mission success on the modern battlefield.
Defense TechHardwareSan Antonio, US
John Goodson(Executive Officer, Director)
BoardMatt Bigge(Director)inMark Hatfield(Director)inSteven Turner(Director)
Co-investorsCapital FactoryDraper AssociatesMVP VenturesTen ElevenBison CapitalCrosslink Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
The Betel Leaf Co.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










